| Product No | EMEA/H/C/000149 |
|---|---|
| Brand Name | EchoGen |
| Nonproprietary Name | dodecafluoropentane |
| API | dodecafluoropentane |
| ATC Code | V08DA |
| Indications | EchoGen is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation.EchoGen should only be used in patients where the study without contrast enhancement is inconclusive. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Sonus Pharmaceuticals Ltd. |
| Status | Withdrawn |
| Authorization Date | 1998-07-17 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information